These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29442075)

  • 1. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.
    Caminiti G; Volterrani M; Iellamo F; Marazzi G; Massaro R; Miceli M; Mammi C; Piepoli M; Fini M; Rosano GM
    J Am Coll Cardiol; 2009 Sep; 54(10):919-27. PubMed ID: 19712802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure.
    Saxton JM; Zwierska I; Mathur A; Channer KS
    BMC Cardiovasc Disord; 2006 Nov; 6():46. PubMed ID: 17137495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
    Malkin CJ; Pugh PJ; West JN; van Beek EJ; Jones TH; Channer KS
    Eur Heart J; 2006 Jan; 27(1):57-64. PubMed ID: 16093267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy and cardiovascular risk.
    Gagliano-Jucá T; Basaria S
    Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone: a vascular hormone in health and disease.
    Kelly DM; Jones TH
    J Endocrinol; 2013 Jun; 217(3):R47-71. PubMed ID: 23549841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone supplementation in heart failure: a meta-analysis.
    Toma M; McAlister FA; Coglianese EE; Vidi V; Vasaiwala S; Bakal JA; Armstrong PW; Ezekowitz JA
    Circ Heart Fail; 2012 May; 5(3):315-21. PubMed ID: 22511747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Tao J; Liu X; Bai W
    Front Endocrinol (Lausanne); 2020; 11():110. PubMed ID: 32231640
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.